The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers

Yaodong Zhang,Zijian Ma,Changxian Li,Cheng Wang,Wangjie Jiang,Jiang Chang,Sheng Han,Zefa Lu,Zicheng Shao,Yirui Wang,Hongwei Wang,Chenyu Jiao,Dong Wang,Xiaofeng Wu,Hongbing Shen,Xuehao Wang,Zhibin Hu,Xiangcheng Li

DOI: https://doi.org/10.1038/s41467-022-30708-7

IF: 16.6

2022-06-01

Nature Communications

Abstract:Abstract Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome-sequencing data of 87 perihilar cholangiocarcinoma (pCCA) and 261 intrahepatic cholangiocarcinoma (iCCA) cases from 3 Asian centers (including 43 pCCAs and 24 iCCAs from our center). iCCA tumours demonstrate a higher tumor mutation burden and copy number alteration burden (CNAB) than pCCA tumours, and high CNAB indicates a poorer pCCA prognosis. We identify 12 significantly mutated genes and 5 focal CNA regions, and demonstrate common mutations in post-transcriptional modification-related potential driver genes METTL14 and RBM10 in pCCA tumours. Finally we demonstrate the tumour-suppressive role of METTL14, a major RNA N6-adenosine methyltransferase (m6A), and illustrate that its loss-of-function mutation R298H may act through m6A modification on potential driver gene MACF1. Our results may be valuable for better understanding of how post-transcriptional modification can affect CCA development, and highlight both similarities and differences between pCCA and iCCA.

multidisciplinary sciences